RSS

chemotherapy

Swiss pharmaceutical group, Helsinn, and professional pharmaceutical subsidiary of CJ Group, CJ Healthcare, have announced that the oral formulation of AKYNZEO has been approved for use in Korea by the Korean Ministry of Food and Drug Safety (MFDS). more

News

Swiss pharmaceutical group, Helsinn, has announced the launch of the intravenous formulation of AKYNZEO (a fixed combination of fosnetupitant, 235 mg, and palonosetron, 0.25 mg) in the US. more

News

Robin Daly, founder of Yes to Life and contributor to The Cancer Revolution believes that the latest trend in healthcare deserves a better rep. more

News

Attack attack attack: Massachusetts Institute of Technology (MIT) designs nanoparticles that can deliver three cancer drugs at once. more

News